Revelation Biosciences, Inc. · NASDAQ:REVB

Revelation Biosciences — 29th International Conference on Advances in Critical Care Nephrology: AKI and CRRT 2024

5 slides from Revelation Biosciences's conference presentation, Mar 12, 2024

  1. Slide 1: Intravenous Gemini for Prevention of Acute Kidney Injury

    Oral Presentation at the 29th International Conference on Advances in Critical Care Nephrology: AKI and CRRT - March 2024 Intravenous GeminiTM for Prevention of Acute Kidney Injury Prophylactic Administration of Gemini (intravenous PHAD®) Reduces Tissue Damage and Improves Kidney Function in a Rat M

  2. Slide 2: Introduction and Methods: Gemini Reprograms Toll-Like Receptor 4 Signaling

    Introduction Gemini is a proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic, detoxified version of lipopolysaccharide (LPS). PHAD stimulates TLR4 to precondition immune cells, including early, robust induction of IL-10, followed by an attenuated induction of IL-6, an

  3. Slide 3: Gemini Preserves Kidney Function and Reduces Injury

    Gemini Preserves Kidney Function and Reduces Injury Kidney Function at 24 and 72 hours Kidney Injury at 72 hours Gemini pretreatment (0.35 mg/kg) significantly preserved kidney function with return to base line faster relative to untreated control animals (Figure 1a and 1b). A similar trend was obse

  4. Slide 4: Gemini Significantly Attenuates Inflammatory Response

    Gemini Significantly Attenuates Inflammatory Response Oral Presentation at the 29th International Conference on Advances in Critical Care Nephrology: AKI and CRRT - March 2024 Figure 3d. Neutrophilic Inflammation at 72 hours2 Figure 3a. Urinary CRP at 24 hours1 1N=16-28, dosed 24 and/or 48 hours pri

  5. Slide 5: Gemini Clinical Evaluation Initiated: Discussion and Conclusions

    Gemini Clinical Evaluation Initiated Discussion Improved kidney function and reduced necrosis likely due to reduction in pro-inflammatory activities, as observed in reduced neutrophil inflammation and reduced local and systemic CRP and IL-6 levels Gemini may halt necroinflammation feedback loop by r

Revelation Biosciences — 29th International Conference on Advances in Critical Care Nephrology: AKI and CRRT 2024 on 6ix